Novartis scores first approval for PIK3CA breast cancer drugThe FDA has approved Novartis’ breast cancer drug Piqray (alpelisib), making it the first marketed treatment targeting the Share XNovartis scores first approval for PIK3CA breast cancer drughttps://pharmaphorum.com/news/novartis-scores-first-approval-for-pik3ca-breast-cancer-drug/
